 | • レポートコード：QY2108PAL8461 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、153ページ • 納品方法：Eメール（納期：1日） • 産業分類：医療装置 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の当調査資料ではグローバルにおける皮膚充填剤・ボツリヌス毒素の市場規模（2016年-2027年）と動向についてまとめました。中国市場については主要プレイヤーの市場シェア、皮膚充填剤・ボツリヌス毒素の種類別市場規模（皮膚充填剤、ボツリヌス毒素）、用途別市場規模（医療、化粧品）も掲載しています。他に、北米・アメリカ市場、ヨーロッパ市場、アジア太平洋・日本市場、中南米市場、中東・アフリカ市場の市場規模、グローバル市場機会・課題・リスク要因、バリューチェーン・販売チャネル、主要プレイヤーの情報なども掲載しています。 ・調査の概要 ・調査のサマリー ・世界の皮膚充填剤・ボツリヌス毒素市場動向 ・グローバル主要プレイヤーの競争状況・市場シェア ・世界における皮膚充填剤・ボツリヌス毒素の種類別市場規模（2016年-2027年）：皮膚充填剤、ボツリヌス毒素 ・世界における皮膚充填剤・ボツリヌス毒素の用途別市場規模（2016年-2027年）：医療、化粧品 ・皮膚充填剤・ボツリヌス毒素の中国市場分析 - 皮膚充填剤・ボツリヌス毒素の中国市場規模（2016年-2027年） - 中国における皮膚充填剤・ボツリヌス毒素の主要プレイヤー別市場シェア - 中国における皮膚充填剤・ボツリヌス毒素の種類別市場規模：皮膚充填剤、ボツリヌス毒素 - 中国における皮膚充填剤・ボツリヌス毒素の用途別市場規模：医療、化粧品 ・皮膚充填剤・ボツリヌス毒素の北米市場（2016年-2027年） ・皮膚充填剤・ボツリヌス毒素のヨーロッパ市場（2016年-2027年） ・皮膚充填剤・ボツリヌス毒素のアジア太平洋市場（2016年-2027年） ・皮膚充填剤・ボツリヌス毒素の中南米市場（2016年-2027年） ・皮膚充填剤・ボツリヌス毒素の中東・アフリカ市場（2016年-2027年） ・主要プレイヤーの情報：Allergan、Galderma、LG Life Science、Merz、Medytox、Bloomage、Bohus BioTech、Sinclair Pharma、IMEIK、Suneva Medical、Teoxane、Luminera、SciVision Biotech、Haohai Bio、Ipsen、LIBP、US World Meds、Hugel、Daewoong ・市場機会・課題・リスク要因分析 ・バリューチェーン・販売チャネル分析 ・... |
Dermal fillers help to diminish facial lines and restore volume and fullness in the face. Botulinum toxin (BTX) is a neurotoxic protein produced by the bacterium clostridium botulinum and related species. It prevents the release of the neurotransmitter acetylcholine from axon endings at the neuromuscular junction and thus causes flaccid paralysis. Infection with the bacterium causes the disease botulism.
Market competition is intense. Allergan, Galderma, LG Life Science, Ipsen, Merz, etc. are the leaders of the industry. Allergan hold the largest market share of 58.7% in 2019.
Market Analysis and Insights: Global and China Dermal Fillers and Botulinum Toxin Market
This report focuses on global and China Dermal Fillers and Botulinum Toxin market.
In 2020, the global Dermal Fillers and Botulinum Toxin market size was US$ 10550 million and it is expected to reach US$ 26720 million by the end of 2027, with a CAGR of 14.2% during 2021-2027. In China the Dermal Fillers and Botulinum Toxin market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.
Global Dermal Fillers and Botulinum Toxin Scope and Market Size
Dermal Fillers and Botulinum Toxin market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Dermal Fillers and Botulinum Toxin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Dermal Fillers and Botulinum Toxin market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.
Segment by Type
Dermal Fillers
Botulinum Toxin
The proportion of dermal fillers in 2019 is about 52%.
Segment by Application
Medical
Cosmetic
The most of dermal fillers and botulinum toxin is used in cosmetic, and the market share of that is about 75.5% in 2019.
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Allergan
Galderma
LG Life Science
Merz
Medytox
Bloomage
Bohus BioTech
Sinclair Pharma
IMEIK
Suneva Medical
Teoxane
Luminera
SciVision Biotech
Haohai Bio
Ipsen
LIBP
US World Meds
Hugel
Daewoong
1 Study Coverage
1.1 Dermal Fillers and Botulinum Toxin Product Introduction
1.2 Market by Type
1.2.1 Global Dermal Fillers and Botulinum Toxin Market Size Growth Rate by Type
1.2.2 Dermal Fillers
1.2.3 Botulinum Toxin
1.3 Market by Application
1.3.1 Global Dermal Fillers and Botulinum Toxin Market Size Growth Rate by Application
1.3.2 Medical
1.3.3 Cosmetic
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Dermal Fillers and Botulinum Toxin Market Size, Estimates and Forecasts
2.1.1 Global Dermal Fillers and Botulinum Toxin Revenue 2016-2027
2.1.2 Global Dermal Fillers and Botulinum Toxin Sales 2016-2027
2.2 Global Dermal Fillers and Botulinum Toxin, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Dermal Fillers and Botulinum Toxin Historical Market Size by Region (2016-2021)
2.3.1 Global Dermal Fillers and Botulinum Toxin Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Dermal Fillers and Botulinum Toxin Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Dermal Fillers and Botulinum Toxin Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Dermal Fillers and Botulinum Toxin Sales Forecast by Region (2022-2027)
2.4.2 Global Dermal Fillers and Botulinum Toxin Revenue Forecast by Region (2022-2027)
3 Global Dermal Fillers and Botulinum Toxin Competitor Landscape by Players
3.1 Global Top Dermal Fillers and Botulinum Toxin Manufacturers by Sales
3.1.1 Global Dermal Fillers and Botulinum Toxin Sales by Manufacturer (2016-2021)
3.1.2 Global Dermal Fillers and Botulinum Toxin Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Dermal Fillers and Botulinum Toxin Manufacturers by Revenue
3.2.1 Key Dermal Fillers and Botulinum Toxin Manufacturers Covered: Ranking by Revenue
3.2.2 Global Dermal Fillers and Botulinum Toxin Revenue by Manufacturers (2016-2021)
3.2.3 Global Dermal Fillers and Botulinum Toxin Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Dermal Fillers and Botulinum Toxin Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Dermal Fillers and Botulinum Toxin Revenue in 2020
3.2.6 Global Dermal Fillers and Botulinum Toxin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Dermal Fillers and Botulinum Toxin Price by Manufacturers
3.4 Global Dermal Fillers and Botulinum Toxin Manufacturing Base Distribution, Product Types
3.4.1 Dermal Fillers and Botulinum Toxin Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Dermal Fillers and Botulinum Toxin Product Type
3.4.3 Date of International Manufacturers Enter into Dermal Fillers and Botulinum Toxin Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Dermal Fillers and Botulinum Toxin Market Size by Type (2016-2021)
4.1.1 Global Dermal Fillers and Botulinum Toxin Sales by Type (2016-2021)
4.1.2 Global Dermal Fillers and Botulinum Toxin Revenue by Type (2016-2021)
4.1.3 Dermal Fillers and Botulinum Toxin Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Dermal Fillers and Botulinum Toxin Market Size Forecast by Type (2022-2027)
4.2.1 Global Dermal Fillers and Botulinum Toxin Sales Forecast by Type (2022-2027)
4.2.2 Global Dermal Fillers and Botulinum Toxin Revenue Forecast by Type (2022-2027)
4.2.3 Dermal Fillers and Botulinum Toxin Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Dermal Fillers and Botulinum Toxin Market Size by Application (2016-2021)
5.1.1 Global Dermal Fillers and Botulinum Toxin Sales by Application (2016-2021)
5.1.2 Global Dermal Fillers and Botulinum Toxin Revenue by Application (2016-2021)
5.1.3 Dermal Fillers and Botulinum Toxin Price by Application (2016-2021)
5.2 Dermal Fillers and Botulinum Toxin Market Size Forecast by Application (2022-2027)
5.2.1 Global Dermal Fillers and Botulinum Toxin Sales Forecast by Application (2022-2027)
5.2.2 Global Dermal Fillers and Botulinum Toxin Revenue Forecast by Application (2022-2027)
5.2.3 Global Dermal Fillers and Botulinum Toxin Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Dermal Fillers and Botulinum Toxin Market Size YoY Growth 2016-2027
6.1.1 China Dermal Fillers and Botulinum Toxin Sales YoY Growth 2016-2027
6.1.2 China Dermal Fillers and Botulinum Toxin Revenue YoY Growth 2016-2027
6.1.3 China Dermal Fillers and Botulinum Toxin Market Share in Global Market 2016-2027
6.2 China Dermal Fillers and Botulinum Toxin Market Size by Players (International and Local Players)
6.2.1 China Top Dermal Fillers and Botulinum Toxin Players by Sales (2016-2021)
6.2.2 China Top Dermal Fillers and Botulinum Toxin Players by Revenue (2016-2021)
6.3 China Dermal Fillers and Botulinum Toxin Historic Market Review by Type (2016-2021)
6.3.1 China Dermal Fillers and Botulinum Toxin Sales Market Share by Type (2016-2021)
6.3.2 China Dermal Fillers and Botulinum Toxin Revenue Market Share by Type (2016-2021)
6.3.3 China Dermal Fillers and Botulinum Toxin Price by Type (2016-2021)
6.4 China Dermal Fillers and Botulinum Toxin Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Dermal Fillers and Botulinum Toxin Sales Forecast by Type (2022-2027)
6.4.2 China Dermal Fillers and Botulinum Toxin Revenue Forecast by Type (2022-2027)
6.4.3 China Dermal Fillers and Botulinum Toxin Price Forecast by Type (2022-2027)
6.5 China Dermal Fillers and Botulinum Toxin Historic Market Review by Application (2016-2021)
6.5.1 China Dermal Fillers and Botulinum Toxin Sales Market Share by Application (2016-2021)
6.5.2 China Dermal Fillers and Botulinum Toxin Revenue Market Share by Application (2016-2021)
6.5.3 China Dermal Fillers and Botulinum Toxin Price by Application (2016-2021)
6.6 China Dermal Fillers and Botulinum Toxin Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Dermal Fillers and Botulinum Toxin Sales Forecast by Application (2022-2027)
6.6.2 China Dermal Fillers and Botulinum Toxin Revenue Forecast by Application (2022-2027)
6.6.3 China Dermal Fillers and Botulinum Toxin Price Forecast by Application (2022-2027)
7 North America
7.1 North America Dermal Fillers and Botulinum Toxin Market Size YoY Growth 2016-2027
7.2 North America Dermal Fillers and Botulinum Toxin Market Facts & Figures by Country
7.2.1 North America Dermal Fillers and Botulinum Toxin Sales by Country (2016-2021)
7.2.2 North America Dermal Fillers and Botulinum Toxin Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Dermal Fillers and Botulinum Toxin Market Size YoY Growth 2016-2027
8.2 Asia Pacific Dermal Fillers and Botulinum Toxin Market Facts & Figures by Region
8.2.1 Asia Pacific Dermal Fillers and Botulinum Toxin Sales by Region (2016-2021)
8.2.2 Asia Pacific Dermal Fillers and Botulinum Toxin Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Dermal Fillers and Botulinum Toxin Market Size YoY Growth 2016-2027
9.2 Europe Dermal Fillers and Botulinum Toxin Market Facts & Figures by Country
9.2.1 Europe Dermal Fillers and Botulinum Toxin Sales by Country (2016-2021)
9.2.2 Europe Dermal Fillers and Botulinum Toxin Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Dermal Fillers and Botulinum Toxin Market Size YoY Growth 2016-2027
10.2 Latin America Dermal Fillers and Botulinum Toxin Market Facts & Figures by Country
10.2.1 Latin America Dermal Fillers and Botulinum Toxin Sales by Country (2016-2021)
10.2.2 Latin America Dermal Fillers and Botulinum Toxin Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Dermal Fillers and Botulinum Toxin Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Dermal Fillers and Botulinum Toxin Market Facts & Figures by Country
11.2.1 Middle East and Africa Dermal Fillers and Botulinum Toxin Sales by Country (2016-2021)
11.2.2 Middle East and Africa Dermal Fillers and Botulinum Toxin Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Allergan
12.1.1 Allergan Corporation Information
12.1.2 Allergan Description and Business Overview
12.1.3 Allergan Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Allergan Dermal Fillers and Botulinum Toxin Products Offered
12.1.5 Allergan Recent Development
12.2 Galderma
12.2.1 Galderma Corporation Information
12.2.2 Galderma Description and Business Overview
12.2.3 Galderma Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Galderma Dermal Fillers and Botulinum Toxin Products Offered
12.2.5 Galderma Recent Development
12.3 LG Life Science
12.3.1 LG Life Science Corporation Information
12.3.2 LG Life Science Description and Business Overview
12.3.3 LG Life Science Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2016-2021)
12.3.4 LG Life Science Dermal Fillers and Botulinum Toxin Products Offered
12.3.5 LG Life Science Recent Development
12.4 Merz
12.4.1 Merz Corporation Information
12.4.2 Merz Description and Business Overview
12.4.3 Merz Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Merz Dermal Fillers and Botulinum Toxin Products Offered
12.4.5 Merz Recent Development
12.5 Medytox
12.5.1 Medytox Corporation Information
12.5.2 Medytox Description and Business Overview
12.5.3 Medytox Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Medytox Dermal Fillers and Botulinum Toxin Products Offered
12.5.5 Medytox Recent Development
12.6 Bloomage
12.6.1 Bloomage Corporation Information
12.6.2 Bloomage Description and Business Overview
12.6.3 Bloomage Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Bloomage Dermal Fillers and Botulinum Toxin Products Offered
12.6.5 Bloomage Recent Development
12.7 Bohus BioTech
12.7.1 Bohus BioTech Corporation Information
12.7.2 Bohus BioTech Description and Business Overview
12.7.3 Bohus BioTech Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Bohus BioTech Dermal Fillers and Botulinum Toxin Products Offered
12.7.5 Bohus BioTech Recent Development
12.8 Sinclair Pharma
12.8.1 Sinclair Pharma Corporation Information
12.8.2 Sinclair Pharma Description and Business Overview
12.8.3 Sinclair Pharma Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Sinclair Pharma Dermal Fillers and Botulinum Toxin Products Offered
12.8.5 Sinclair Pharma Recent Development
12.9 IMEIK
12.9.1 IMEIK Corporation Information
12.9.2 IMEIK Description and Business Overview
12.9.3 IMEIK Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2016-2021)
12.9.4 IMEIK Dermal Fillers and Botulinum Toxin Products Offered
12.9.5 IMEIK Recent Development
12.10 Suneva Medical
12.10.1 Suneva Medical Corporation Information
12.10.2 Suneva Medical Description and Business Overview
12.10.3 Suneva Medical Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Suneva Medical Dermal Fillers and Botulinum Toxin Products Offered
12.10.5 Suneva Medical Recent Development
12.11 Allergan
12.11.1 Allergan Corporation Information
12.11.2 Allergan Description and Business Overview
12.11.3 Allergan Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Allergan Dermal Fillers and Botulinum Toxin Products Offered
12.11.5 Allergan Recent Development
12.12 Luminera
12.12.1 Luminera Corporation Information
12.12.2 Luminera Description and Business Overview
12.12.3 Luminera Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Luminera Products Offered
12.12.5 Luminera Recent Development
12.13 SciVision Biotech
12.13.1 SciVision Biotech Corporation Information
12.13.2 SciVision Biotech Description and Business Overview
12.13.3 SciVision Biotech Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2016-2021)
12.13.4 SciVision Biotech Products Offered
12.13.5 SciVision Biotech Recent Development
12.14 Haohai Bio
12.14.1 Haohai Bio Corporation Information
12.14.2 Haohai Bio Description and Business Overview
12.14.3 Haohai Bio Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Haohai Bio Products Offered
12.14.5 Haohai Bio Recent Development
12.15 Ipsen
12.15.1 Ipsen Corporation Information
12.15.2 Ipsen Description and Business Overview
12.15.3 Ipsen Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Ipsen Products Offered
12.15.5 Ipsen Recent Development
12.16 LIBP
12.16.1 LIBP Corporation Information
12.16.2 LIBP Description and Business Overview
12.16.3 LIBP Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2016-2021)
12.16.4 LIBP Products Offered
12.16.5 LIBP Recent Development
12.17 US World Meds
12.17.1 US World Meds Corporation Information
12.17.2 US World Meds Description and Business Overview
12.17.3 US World Meds Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2016-2021)
12.17.4 US World Meds Products Offered
12.17.5 US World Meds Recent Development
12.18 Hugel
12.18.1 Hugel Corporation Information
12.18.2 Hugel Description and Business Overview
12.18.3 Hugel Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2016-2021)
12.18.4 Hugel Products Offered
12.18.5 Hugel Recent Development
12.19 Daewoong
12.19.1 Daewoong Corporation Information
12.19.2 Daewoong Description and Business Overview
12.19.3 Daewoong Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2016-2021)
12.19.4 Daewoong Products Offered
12.19.5 Daewoong Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Dermal Fillers and Botulinum Toxin Industry Trends
13.2 Dermal Fillers and Botulinum Toxin Market Drivers
13.3 Dermal Fillers and Botulinum Toxin Market Challenges
13.4 Dermal Fillers and Botulinum Toxin Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Dermal Fillers and Botulinum Toxin Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Global Dermal Fillers and Botulinum Toxin Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Dermal Fillers
Table 3. Major Manufacturers of Botulinum Toxin
Table 4. Global Dermal Fillers and Botulinum Toxin Market Size Growth Rate by Application (2021-2027) & (K Units)
Table 5. Global Dermal Fillers and Botulinum Toxin Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 6. Global Dermal Fillers and Botulinum Toxin Sales by Regions (2016-2021) & (K Units)
Table 7. Global Dermal Fillers and Botulinum Toxin Sales Market Share by Regions (2016-2021)
Table 8. Global Dermal Fillers and Botulinum Toxin Revenue by Regions (2016-2021) & (US$ Million)
Table 9. Global Dermal Fillers and Botulinum Toxin Sales Forecast by Region (2022-2027) & (K Units)
Table 10. Global Dermal Fillers and Botulinum Toxin Sales Market Share Forecast by Region (2022-2027)
Table 11. Global Dermal Fillers and Botulinum Toxin Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 12. Global Dermal Fillers and Botulinum Toxin Revenue Market Share Forecast by Region (2022-2027)
Table 13. Global Dermal Fillers and Botulinum Toxin Sales by Manufacturers (2016-2021) (K Units)
Table 14. Global Dermal Fillers and Botulinum Toxin Sales Share by Manufacturers (2016-2021)
Table 15. Ranking of Global Top Dermal Fillers and Botulinum Toxin Manufacturers by Revenue (US$ Million) in 2020
Table 16. Dermal Fillers and Botulinum Toxin Revenue by Manufacturers (2016-2021) (US$ Million)
Table 17. Dermal Fillers and Botulinum Toxin Revenue Share by Manufacturers (2016-2021)
Table 18. Global Dermal Fillers and Botulinum Toxin Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 19. Global Dermal Fillers and Botulinum Toxin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dermal Fillers and Botulinum Toxin as of 2020)
Table 20. Key Manufacturers Dermal Fillers and Botulinum Toxin Price (2016-2021) (US$/Unit)
Table 21. Dermal Fillers and Botulinum Toxin Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Dermal Fillers and Botulinum Toxin Product Type
Table 23. Date of International Manufacturers Enter into Dermal Fillers and Botulinum Toxin Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Dermal Fillers and Botulinum Toxin Sales by Type (2016-2021) (K Units)
Table 26. Global Dermal Fillers and Botulinum Toxin Sales Share by Type (2016-2021)
Table 27. Global Dermal Fillers and Botulinum Toxin Revenue by Type (2016-2021) (US$ Million)
Table 28. Global Dermal Fillers and Botulinum Toxin Revenue Share by Type (2016-2021)
Table 29. Dermal Fillers and Botulinum Toxin Average Selling Price (ASP) by Type (2016-2021) & (US$/Unit)
Table 30. Global Dermal Fillers and Botulinum Toxin Sales Forecast by Type (2022-2027) & (K Units)
Table 31. Global Dermal Fillers and Botulinum Toxin Sales Market Share Forecast by Type (2022-2027)
Table 32. Global Dermal Fillers and Botulinum Toxin Revenue Forecast V (2022-2027) & (US$ Million)
Table 33. Global Dermal Fillers and Botulinum Toxin Revenue Market Share Forecast by Type (2022-2027)
Table 34. Global Dermal Fillers and Botulinum Toxin Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Unit)
Table 35. Global Dermal Fillers and Botulinum Toxin Sales by Application (2016-2021) (K Units)
Table 36. Global Dermal Fillers and Botulinum Toxin Sales Share by Application (2016-2021)
Table 37. Global Dermal Fillers and Botulinum Toxin Revenue by Application (2016-2021) (US$ Million)
Table 38. Global Dermal Fillers and Botulinum Toxin Revenue Share by Application (2016-2021)
Table 39. Dermal Fillers and Botulinum Toxin Average Selling Price (ASP) by Application (2016-2021) & (US$/Unit)
Table 40. Global Dermal Fillers and Botulinum Toxin Sales Forecast by Application (2022-2027) & (K Units)
Table 41. Global Dermal Fillers and Botulinum Toxin Sales Market Share Forecast by Application (2022-2027)
Table 42. Global Dermal Fillers and Botulinum Toxin Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 43. Global Dermal Fillers and Botulinum Toxin Revenue Market Share Forecast by Application (2022-2027)
Table 44. Global Dermal Fillers and Botulinum Toxin Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Unit)
Table 45. China Dermal Fillers and Botulinum Toxin Sales (K Units) of Key Companies (2016-2021)
Table 46. China Dermal Fillers and Botulinum Toxin Sales Share by Company (2016-2021)
Table 47. China Dermal Fillers and Botulinum Toxin Revenue (US$ Million) by Company (2016-2021)
Table 48. China Dermal Fillers and Botulinum Toxin Revenue Share by Company (2016-2021)
Table 49. China Dermal Fillers and Botulinum Toxin Sales (K Units) by Type (2016-2021)
Table 50. China Dermal Fillers and Botulinum Toxin Sales Share by Type (2016-2021)
Table 51. China Dermal Fillers and Botulinum Toxin Revenue (US$ Million) Market Share by Type (2016-2021)
Table 52. China Dermal Fillers and Botulinum Toxin Price (US$/Unit) by Type (2016-2021)
Table 53. China Dermal Fillers and Botulinum Toxin Sales (K Units) by Type (2022-2027)
Table 54. China Dermal Fillers and Botulinum Toxin Sales Share by Type (2022-2027)
Table 55. China Dermal Fillers and Botulinum Toxin Revenue (US$ Million) Market Share by Type (2022-2027)
Table 56. China Dermal Fillers and Botulinum Toxin Revenue Share by Type (2022-2027)
Table 57. China Dermal Fillers and Botulinum Toxin Price (US$/Unit) by Type (2022-2027)
Table 58. China Dermal Fillers and Botulinum Toxin Sales (K Units) by Application (2016-2021)
Table 59. China Dermal Fillers and Botulinum Toxin Sales Share by Application (2016-2021)
Table 60. China Dermal Fillers and Botulinum Toxin Revenue (US$ Million) Market Share by Application (2016-2021)
Table 61. China Dermal Fillers and Botulinum Toxin Price (US$/Unit) by Application (2016-2021)
Table 62. China Dermal Fillers and Botulinum Toxin Sales (K Units) by Application (2022-2027)
Table 63. China Dermal Fillers and Botulinum Toxin Sales Share by Application (2022-2027)
Table 64. China Dermal Fillers and Botulinum Toxin Revenue (US$ Million) Market Share by Application (2022-2027)
Table 65. China Dermal Fillers and Botulinum Toxin Revenue Share by Application (2022-2027)
Table 66. China Dermal Fillers and Botulinum Toxin Price (US$/Unit) by Application (2022-2027)
Table 67. North America Dermal Fillers and Botulinum Toxin Sales by Country (2016-2021) & (K Units)
Table 68. North America Dermal Fillers and Botulinum Toxin Sales Market Share by Country (2016-2021)
Table 69. North America Dermal Fillers and Botulinum Toxin Revenue by Country (2016-2021) & (US$ Million)
Table 70. North America Dermal Fillers and Botulinum Toxin Revenue Market Share by Country (2016-2021)
Table 71. Asia Pacific Dermal Fillers and Botulinum Toxin Sales by Region (2016-2021) & (K Units)
Table 72. Asia Pacific Dermal Fillers and Botulinum Toxin Sales Market Share by Region (2016-2021)
Table 73. Asia Pacific Dermal Fillers and Botulinum Toxin Revenue by Region (2016-2021) & (US$ Million)
Table 74. Asia Pacific Dermal Fillers and Botulinum Toxin Revenue Market Share by Region (2016-2021)
Table 75. Europe Dermal Fillers and Botulinum Toxin Sales by Country (2016-2021) & (K Units)
Table 76. Europe Dermal Fillers and Botulinum Toxin Sales Market Share by Country (2016-2021)
Table 77. Europe Dermal Fillers and Botulinum Toxin Revenue by Country (2016-2021) & (US$ Million)
Table 78. Europe Dermal Fillers and Botulinum Toxin Revenue Market Share by Country (2016-2021)
Table 79. Latin America Dermal Fillers and Botulinum Toxin Sales by Country (2016-2021) & (K Units)
Table 80. Latin America Dermal Fillers and Botulinum Toxin Sales Market Share by Country (2016-2021)
Table 81. Latin Americaa Dermal Fillers and Botulinum Toxin Revenue by Country (2016-2021) & (US$ Million)
Table 82. Latin America Dermal Fillers and Botulinum Toxin Revenue Market Share by Country (2016-2021)
Table 83. Middle East and Africa Dermal Fillers and Botulinum Toxin Sales by Country (2016-2021) & (K Units)
Table 84. Middle East and Africa Dermal Fillers and Botulinum Toxin Sales Market Share by Country (2016-2021)
Table 85. Middle East and Africa Dermal Fillers and Botulinum Toxin Revenue by Country (2016-2021) & (US$ Million)
Table 86. Middle East and Africa Dermal Fillers and Botulinum Toxin Revenue Market Share by Country (2016-2021)
Table 87. Allergan Corporation Information
Table 88. Allergan Description and Business Overview
Table 89. Allergan Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 90. Allergan Dermal Fillers and Botulinum Toxin Product
Table 91. Allergan Recent Development
Table 92. Galderma Corporation Information
Table 93. Galderma Description and Business Overview
Table 94. Galderma Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 95. Galderma Product
Table 96. Galderma Recent Development
Table 97. LG Life Science Corporation Information
Table 98. LG Life Science Description and Business Overview
Table 99. LG Life Science Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 100. LG Life Science Product
Table 101. LG Life Science Recent Development
Table 102. Merz Corporation Information
Table 103. Merz Description and Business Overview
Table 104. Merz Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 105. Merz Product
Table 106. Merz Recent Development
Table 107. Medytox Corporation Information
Table 108. Medytox Description and Business Overview
Table 109. Medytox Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 110. Medytox Product
Table 111. Medytox Recent Development
Table 112. Bloomage Corporation Information
Table 113. Bloomage Description and Business Overview
Table 114. Bloomage Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 115. Bloomage Product
Table 116. Bloomage Recent Development
Table 117. Bohus BioTech Corporation Information
Table 118. Bohus BioTech Description and Business Overview
Table 119. Bohus BioTech Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 120. Bohus BioTech Product
Table 121. Bohus BioTech Recent Development
Table 122. Sinclair Pharma Corporation Information
Table 123. Sinclair Pharma Description and Business Overview
Table 124. Sinclair Pharma Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 125. Sinclair Pharma Product
Table 126. Sinclair Pharma Recent Development
Table 127. IMEIK Corporation Information
Table 128. IMEIK Description and Business Overview
Table 129. IMEIK Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 130. IMEIK Product
Table 131. IMEIK Recent Development
Table 132. Suneva Medical Corporation Information
Table 133. Suneva Medical Description and Business Overview
Table 134. Suneva Medical Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 135. Suneva Medical Product
Table 136. Suneva Medical Recent Development
Table 137. Teoxane Corporation Information
Table 138. Teoxane Description and Business Overview
Table 139. Teoxane Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 140. Teoxane Product
Table 141. Teoxane Recent Development
Table 142. Luminera Corporation Information
Table 143. Luminera Description and Business Overview
Table 144. Luminera Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 145. Luminera Product
Table 146. Luminera Recent Development
Table 147. SciVision Biotech Corporation Information
Table 148. SciVision Biotech Description and Business Overview
Table 149. SciVision Biotech Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 150. SciVision Biotech Product
Table 151. SciVision Biotech Recent Development
Table 152. Haohai Bio Corporation Information
Table 153. Haohai Bio Description and Business Overview
Table 154. Haohai Bio Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 155. Haohai Bio Product
Table 156. Haohai Bio Recent Development
Table 157. Ipsen Corporation Information
Table 158. Ipsen Description and Business Overview
Table 159. Ipsen Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 160. Ipsen Product
Table 161. Ipsen Recent Development
Table 162. LIBP Corporation Information
Table 163. LIBP Description and Business Overview
Table 164. LIBP Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 165. LIBP Product
Table 166. LIBP Recent Development
Table 167. US World Meds Corporation Information
Table 168. US World Meds Description and Business Overview
Table 169. US World Meds Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 170. US World Meds Product
Table 171. US World Meds Recent Development
Table 172. Hugel Corporation Information
Table 173. Hugel Description and Business Overview
Table 174. Hugel Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 175. Hugel Product
Table 176. Hugel Recent Development
Table 177. Daewoong Corporation Information
Table 178. Daewoong Description and Business Overview
Table 179. Daewoong Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 180. Daewoong Product
Table 181. Daewoong Recent Development
Table 182. Dermal Fillers and Botulinum Toxin Market Trends
Table 183. Dermal Fillers and Botulinum Toxin Market Drivers
Table 184. Dermal Fillers and Botulinum Toxin Market Challenges
Table 185. Dermal Fillers and Botulinum Toxin Market Restraints
Table 186. Dermal Fillers and Botulinum Toxin Customers List
Table 187. Dermal Fillers and Botulinum Toxin Distributors List
Table 188. Research Programs/Design for This Report
Table 189. Key Data Information from Secondary Sources
Table 190. Key Data Information from Primary Sources
List of Figures
Figure 1. Dermal Fillers and Botulinum Toxin Product Picture
Figure 2. Global Dermal Fillers and Botulinum Toxin Sales Market Share by Type in 2020 & 2027
Figure 3. Dermal Fillers Product Picture
Figure 4. Botulinum Toxin Product Picture
Figure 5. Global Dermal Fillers and Botulinum Toxin Sales Market Share by Application in 2020 & 2027
Figure 6. Medical
Figure 7. Cosmetic
Figure 8. Dermal Fillers and Botulinum Toxin Report Years Considered
Figure 9. Global Dermal Fillers and Botulinum Toxin Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Dermal Fillers and Botulinum Toxin Market Size 2016-2027 (US$ Million)
Figure 11. Global Dermal Fillers and Botulinum Toxin Sales 2016-2027 (K Units)
Figure 12. Global Dermal Fillers and Botulinum Toxin Market Size Market Share by Region: 2021 Versus 2027
Figure 13. Global Dermal Fillers and Botulinum Toxin Sales Market Share by Region (2016-2021)
Figure 14. Global Dermal Fillers and Botulinum Toxin Sales Market Share by Region in 2020
Figure 15. Global Dermal Fillers and Botulinum Toxin Revenue Market Share by Region (2016-2021)
Figure 16. Global Dermal Fillers and Botulinum Toxin Revenue Market Share by Region in 2020
Figure 17. Global Dermal Fillers and Botulinum Toxin Sales Share by Manufacturer in 2020
Figure 18. The Top 10 and 5 Players Market Share by Dermal Fillers and Botulinum Toxin Revenue in 2020
Figure 19. Dermal Fillers and Botulinum Toxin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 20. Global Dermal Fillers and Botulinum Toxin Sales Market Share by Type (2016-2021)
Figure 21. Global Dermal Fillers and Botulinum Toxin Sales Market Share by Type in 2020
Figure 22. Global Dermal Fillers and Botulinum Toxin Revenue Market Share by Type (2016-2021)
Figure 23. Global Dermal Fillers and Botulinum Toxin Revenue Market Share by Type in 2020
Figure 24. Global Dermal Fillers and Botulinum Toxin Sales Market Share by Application (2016-2021)
Figure 25. Global Dermal Fillers and Botulinum Toxin Sales Market Share by Application in 2020
Figure 26. Global Dermal Fillers and Botulinum Toxin Revenue Market Share by Application (2016-2021)
Figure 27. Global Dermal Fillers and Botulinum Toxin Revenue Market Share by Application in 2020
Figure 28. China Dermal Fillers and Botulinum Toxin Sales Growth Rate 2016-2027 (K Units)
Figure 29. China Dermal Fillers and Botulinum Toxin Revenue Growth Rate 2016-2027 (US$ Million)
Figure 30. China Dermal Fillers and Botulinum Toxin Market Share in Global Market 2016-2027
Figure 31. China 5 and 10 Largest Dermal Fillers and Botulinum Toxin Players Market Share by Revenue in Dermal Fillers and Botulinum Toxin in 2020
Figure 32. China Dermal Fillers and Botulinum Toxin Revenue Share by Type (2016-2021)
Figure 33. China Dermal Fillers and Botulinum Toxin Revenue Growth Rate by Type in 2016 & 2020
Figure 34. China Dermal Fillers and Botulinum Toxin Revenue Share by Application (2016-2021)
Figure 35. China Dermal Fillers and Botulinum Toxin Revenue Growth Rate by Application in 2016 & 2020
Figure 36. North America Dermal Fillers and Botulinum Toxin Sales Growth Rate 2016-2021 (K Units)
Figure 37. North America Dermal Fillers and Botulinum Toxin Revenue Growth Rate 2016-2021 (US$ Million)
Figure 38. North America Dermal Fillers and Botulinum Toxin Sales Market Share by Country in 2020
Figure 39. North America Dermal Fillers and Botulinum Toxin Revenue Market Share by Country in 2020
Figure 40. U.S. Dermal Fillers and Botulinum Toxin Sales Growth Rate (2016-2021) (K Units)
Figure 41. U.S. Dermal Fillers and Botulinum Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Canada Dermal Fillers and Botulinum Toxin Sales Growth Rate (2016-2021) (K Units)
Figure 43. Canada Dermal Fillers and Botulinum Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Europe Dermal Fillers and Botulinum Toxin Sales Growth Rate 2016-2021 (K Units)
Figure 45. Europe Dermal Fillers and Botulinum Toxin Revenue Growth Rate 2016-2021 (US$ Million)
Figure 46. Europe Dermal Fillers and Botulinum Toxin Sales Market Share by Country in 2020
Figure 47. Europe Dermal Fillers and Botulinum Toxin Revenue Market Share by Country in 2020
Figure 48. Germany Dermal Fillers and Botulinum Toxin Sales Growth Rate (2016-2021) (K Units)
Figure 49. Germany Dermal Fillers and Botulinum Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. France Dermal Fillers and Botulinum Toxin Sales Growth Rate (2016-2021) (K Units)
Figure 51. France Dermal Fillers and Botulinum Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 52. U.K. Dermal Fillers and Botulinum Toxin Sales Growth Rate (2016-2021) (K Units)
Figure 53. U.K. Dermal Fillers and Botulinum Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 54. Italy Dermal Fillers and Botulinum Toxin Sales Growth Rate (2016-2021) (K Units)
Figure 55. Italy Dermal Fillers and Botulinum Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 56. Russia Dermal Fillers and Botulinum Toxin Sales Growth Rate (2016-2021) (K Units)
Figure 57. Russia Dermal Fillers and Botulinum Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. Asia Pacific Dermal Fillers and Botulinum Toxin Sales Growth Rate 2016-2021 (K Units)
Figure 59. Asia Pacific Dermal Fillers and Botulinum Toxin Revenue Growth Rate 2016-2021 (US$ Million)
Figure 60. Asia Pacific Dermal Fillers and Botulinum Toxin Sales Market Share by Region in 2020
Figure 61. Asia Pacific Dermal Fillers and Botulinum Toxin Revenue Market Share by Region in 2020
Figure 62. China Dermal Fillers and Botulinum Toxin Sales Growth Rate (2016-2021) (K Units)
Figure 63. China Dermal Fillers and Botulinum Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 64. Japan Dermal Fillers and Botulinum Toxin Sales Growth Rate (2016-2021) (K Units)
Figure 65. Japan Dermal Fillers and Botulinum Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 66. South Korea Dermal Fillers and Botulinum Toxin Sales Growth Rate (2016-2021) (K Units)
Figure 67. South Korea Dermal Fillers and Botulinum Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 68. India Dermal Fillers and Botulinum Toxin Sales Growth Rate (2016-2021) (K Units)
Figure 69. India Dermal Fillers and Botulinum Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 70. Australia Dermal Fillers and Botulinum Toxin Sales Growth Rate (2016-2021) (K Units)
Figure 71. Australia Dermal Fillers and Botulinum Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 72. Taiwan Dermal Fillers and Botulinum Toxin Sales Growth Rate (2016-2021) (K Units)
Figure 73. Taiwan Dermal Fillers and Botulinum Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 74. Indonesia Dermal Fillers and Botulinum Toxin Sales Growth Rate (2016-2021) (K Units)
Figure 75. Indonesia Dermal Fillers and Botulinum Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 76. Thailand Dermal Fillers and Botulinum Toxin Sales Growth Rate (2016-2021) (K Units)
Figure 77. Thailand Dermal Fillers and Botulinum Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 78. Malaysia Dermal Fillers and Botulinum Toxin Sales Growth Rate (2016-2021) (K Units)
Figure 79. Malaysia Dermal Fillers and Botulinum Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 80. Philippines Dermal Fillers and Botulinum Toxin Sales Growth Rate (2016-2021) (K Units)
Figure 81. Philippines Dermal Fillers and Botulinum Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 82. Vietnam Dermal Fillers and Botulinum Toxin Sales Growth Rate (2016-2021) (K Units)
Figure 83. Vietnam Dermal Fillers and Botulinum Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 84. Latin America Dermal Fillers and Botulinum Toxin Sales Growth Rate 2016-2021 (K Units)
Figure 85. Latin America Dermal Fillers and Botulinum Toxin Revenue Growth Rate 2016-2021 (US$ Million)
Figure 86. Latin America Dermal Fillers and Botulinum Toxin Sales Market Share by Country in 2020
Figure 87. Latin America Dermal Fillers and Botulinum Toxin Revenue Market Share by Country in 2020
Figure 88. Mexico Dermal Fillers and Botulinum Toxin Sales Growth Rate (2016-2021) (K Units)
Figure 89. Mexico Dermal Fillers and Botulinum Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 90. Brazil Dermal Fillers and Botulinum Toxin Sales Growth Rate (2016-2021) (K Units)
Figure 91. Brazil Dermal Fillers and Botulinum Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 92. Argentina Dermal Fillers and Botulinum Toxin Sales Growth Rate (2016-2021) (K Units)
Figure 93. Argentina Dermal Fillers and Botulinum Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 94. Middle East and Africa Dermal Fillers and Botulinum Toxin Sales Growth Rate 2016-2021 (K Units)
Figure 95. Middle East and Africa Dermal Fillers and Botulinum Toxin Revenue Growth Rate 2016-2021 (US$ Million)
Figure 96. Middle East and Africa Dermal Fillers and Botulinum Toxin Sales Market Share by Country in 2020
Figure 97. Middle East and Africa Dermal Fillers and Botulinum Toxin Revenue Market Share by Country in 2020
Figure 98. Turkey Dermal Fillers and Botulinum Toxin Sales Growth Rate (2016-2021) (K Units)
Figure 99. Turkey Dermal Fillers and Botulinum Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 100. Saudi Arabia Dermal Fillers and Botulinum Toxin Sales Growth Rate (2016-2021) (K Units)
Figure 101. Saudi Arabia Dermal Fillers and Botulinum Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 102. UAE Dermal Fillers and Botulinum Toxin Sales Growth Rate (2016-2021) (K Units)
Figure 103. UAE Dermal Fillers and Botulinum Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 104. Dermal Fillers and Botulinum Toxin Value Chain
Figure 105. Channels of Distribution
Figure 106. Distributors Profiles
Figure 107. Bottom-up and Top-down Approaches for This Report
Figure 108. Data Triangulation
Figure 109. Key Executives Interviewed
皮膚フィラー・ボツリヌス毒素の世界市場 2020年 Market Overview The global Dermal Fillers and Botulinum Toxin market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Dermal Fil…- 皮膚充填剤の世界及び中国市場 Dermal fillers help to diminish facial lines and restore volume and fullness in the face. Dermal fillers can be used to: plump thin lips, enhance shallow contours, soften facial creases and wrinkles and improve the appearance of recessed scars Dermal fillers can be very helpful in those with early s…
- 皮膚用フィラーの世界市場 2020年 Market Overview The Dermal Fillers market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …
- ヒアルロン酸皮膚充填剤の世界市場 2020年 Market Overview The Hyaluronic Acid Based Dermal Fillers market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chai…
- 毒素の世界及び中国市場 Botulinum toxin (BTX) is a neurotoxic protein produced by the bacterium Clostridium botulinum and related species. It prevents the release of the neurotransmitter acetylcholine from axon endings at the neuromuscular junction and thus causes flaccid paralysis. Infection with the bacterium causes the …